The pharmaceutical industry has seen a lot of change in the last 21 years. In 1996 the internet was relatively new and limited to computer access, mobile devices were bulky and expensive, and security concerns were primarily physical. Similarly, a lot has changed with regards to business, manufacturing and regulation, and Richard M Johnson, President/CEO, Parenteral Drug Association, shares his perspective on these developments.
IN THE mid-1990s the leading products were small molecule, oral solid dosage (OSD) forms. Most products were developed in house within pharma R&D and, while success rates were not high, the profitability of pharmaceuticals made the shotgun approach feasible.
This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.
Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.
What you’ll discover:
Key trends shaping the pharmaceutical formulation sector
Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
Can’t attend live? No worries – register to receive the recording post-event.
The last 21 years have seen dramatic changes to this landscape: mega mergers and consolidation of companies have resulted in consolidation of manufacturing and R&D. There has been increasing dependence on outsourcing – both for manufacturing and R&D – which has led to integration challenges and increased focus on a diverse and vulnerable supply chain.
[insert_php] if ( zmember_valid_subscription() ) { echo ‘
DOWNLOAD THE ENTIRE 21st ANNIVERSARY SUPPLEMENT NOW
Our 21 @ 21 Anniversary Supplement is just one of the many resources a free subscription to European Pharmaceutical Review provides. If you are already a subscriber, login to download the PDF.
Not yet a subscriber? Join our growing community of thousands of industry professionals and gain access to:
Bi-monthly issues in print and/or digital format
Case studies, whitepapers, webinars and industry-leading content
Breaking news and features
Our extensive online archive of over 8,500 articles and past issues
Patent expiry for the majority of leading small molecule products, with dramatic loss of market share, has focused the industry on cost controls and rationalisation. Decline in top-line revenue adds pressure on pharma companies to reduce expenses to maintain bottom line revenue. This has caused rationalisation of overcapacity, lack of recapitalisation, and pricing pressure on materials and cost of goods.
Government pricing pressure is increasing worldwide and this same period has also seen tremendous growth in globalisation, with recognition of the growing importance of ‘pharmerging’ markets, as global companies increasingly focusing on manufacturing and sales in these locations. The rationalisation of manufacturing capacity is occurring while global demand for pharmaceuticals continues to rise.
This period has also seen the emergence of biologic therapies, which now account for most of the leading products on the market today. For a period, this reduced the impact of the ‘patent cliff’, but the growing acceptance of biosimilars is beginning to have a similar effect. Many of these biologic products are more expensive, renewing the debate about cost/benefit and the focus on pricing.
Manufacturing
The technology to manufacture OSD is very different from manufacturing sterile products – and the manufacture of the drug substance (API) is even more complex. The rise of biopharmaceuticals has led to new challenges and innovations. We have seen an increased proportion of ‘cold chain’ products, which, in addition to concerns about supply chain security, has given new focus to distribution.
Higher yields have meant continued reduction in the size of equipment and increasing use of single-use technologies that have allowed dramatic reduction in facility footprint and associated costs. We have witnessed the change from manually intensive aseptic processes to highly automated equipment with advanced environmental controls. Analysis of product has moved from laboratory to advanced instruments, including some uptake of in-process analytics. Most dramatically, however, is the shift from paper records to terabytes of electronic data. Richard M Johnson, President/CEO, Parenteral Drug Association
The increase in development of combination products – drug/biologic and device – has been rife but new integration with diagnostics and software are promising even more benefits as well as challenges. New therapies are emerging from enhanced understanding of the genetic and individual contributors to disease, which brings the possibility to customise treatment in a more focused way. Each of these advances challenge the existing paradigm of manufacturing and control.
Regulation
Our regulatory framework is a further aspect that’s changed. Twenty years ago we saw the beginnings of EU integration and international harmonisation. The understanding of GMP has steadily harmonised, but the legal and regulatory framework has unfortunately not kept pace, with some markets using regulation as de facto trade barriers. We are seeing greater cooperation and exchange of information among global regulators, as they recognise the need to adapt to the changing global supply chain, but this still primarily focuses on GMP enforcement. The licensing of products is still highly fragmented, and the impact on manufacturing and post-approval changes has continued to be a barrier to innovation.
The future of therapies to solve medical needs is exciting, but will inevitably create challenges to business, manufacturing and regulation. The pace of change will only increase. It falls to all of us to embrace these changes and deliver better outcomes to the patients we serve.
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.